NorthRock Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.28M Sell
27,676
-1,059
-4% -$49K 0.03% 199
2025
Q1
$1.75M Buy
28,735
+1,976
+7% +$121K 0.06% 131
2024
Q4
$1.51M Buy
26,759
+594
+2% +$33.6K 0.05% 145
2024
Q3
$1.35M Buy
26,165
+9,142
+54% +$473K 0.04% 174
2024
Q2
$707K Buy
17,023
+1,486
+10% +$61.7K 0.03% 255
2024
Q1
$843K Buy
15,537
+1,250
+9% +$67.8K 0.03% 228
2023
Q4
$733K Buy
14,287
+3,781
+36% +$194K 0.03% 232
2023
Q3
$610K Buy
10,506
+624
+6% +$36.2K 0.06% 128
2023
Q2
$632K Buy
9,882
+664
+7% +$42.5K 0.07% 112
2023
Q1
$639K Sell
9,218
-2,360
-20% -$164K 0.07% 125
2022
Q4
$833K Buy
11,578
+3,459
+43% +$249K 0.09% 110
2022
Q3
$577K Sell
8,119
-1,045
-11% -$74.3K 0.07% 131
2022
Q2
$706K Sell
9,164
-223
-2% -$17.2K 0.07% 120
2022
Q1
$686K Buy
9,387
+2,379
+34% +$174K 0.06% 141
2021
Q4
$437K Buy
7,008
+1,460
+26% +$91K 0.03% 192
2021
Q3
$328K Buy
5,548
+571
+11% +$33.8K 0.03% 198
2021
Q2
$333K Buy
4,977
+251
+5% +$16.8K 0.03% 184
2021
Q1
$298K Sell
4,726
-1,604
-25% -$101K 0.03% 176
2020
Q4
$393K Sell
6,330
-981
-13% -$60.9K 0.04% 147
2020
Q3
$441K Sell
7,311
-1,056
-13% -$63.7K 0.05% 131
2020
Q2
$492K Buy
8,367
+414
+5% +$24.3K 0.06% 118
2020
Q1
$443K Sell
7,953
-6,052
-43% -$337K 0.06% 118
2019
Q4
$899K Buy
14,005
+8,750
+167% +$562K 0.1% 107
2019
Q3
$266K Buy
+5,255
New +$266K 0.04% 181
2019
Q1
Sell
-4,480
Closed -$232K 96
2018
Q4
$232K Buy
+4,480
New +$232K 0.07% 82